Skip to main content
SpringerLink
Log in
Book cover

Tumor Prevention and Genetics

  • Conference proceedings
  • © 2003

Overview

Editors:
  1. Hans-Jörg Senn

    1. Zentrum für Tumordiagnostik und Prävention, St. Gallen, Switzerland

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Rudolf Morant

    1. Zentrum für Tumordiagnostik und Prävention, St. Gallen, Switzerland

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Recent Results in Cancer Research (RECENTCANCER, volume 163)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (24 papers)

  1. Front Matter

    Pages I-VII
    Download chapter PDF

  2. Introduction

    1. Introduction

      • Hans-Jörg Senn
      Pages 1-3

  3. Latest News in Cancer Genetics

    1. Front Matter

      Pages 5-5
      Download chapter PDF

    2. Genetic Susceptibility, Predicting Risk and Preventing Cancer

      • Paul D. P. Pharoah
      Pages 7-18

    3. Novel Approaches to Identify Low-Penetrance Cancer Susceptibility Genes Using Mouse Models

      • John P. de Koning, Jian-Hua Mao, Allan Balmain
      Pages 19-27

  4. Assessing New Cancer Susceptibility Genes

    1. Front Matter

      Pages 29-29
      Download chapter PDF

    2. Development of Novel Selective Cell Ablation in the Mammary Gland and Brain to Study Cell-Cell Interactions and Chemoprevention

      • Barry A. Gusterson, Wei Cui, A. John Clark
      Pages 31-45

    3. Mouse Skin as a Model for Cancer Chemoprevention by Nonsteroidal Anti-Inflammatory Drugs

      • Friedrich Marks, Gerhard Fürstenberger, Gitta Neufang, Karin Müller-Decker
      Pages 46-57

    4. Preclinical Models for Chemoprevention of Colon Cancer

      • Eugene W. Gerner, Natalia A. Ignatenko, David G. Besselsen
      Pages 58-71

    5. New Cancer Biomarkers Deriving from NCI Early Detection Research

      • Mukesh Verma, Sudhir Srivastava
      Pages 72-84

  6. Secondary Prevention of Breast Cancer: The Mammography Controversy

    1. Front Matter

      Pages 113-113
      Download chapter PDF

    2. Is Mammography Screening for Breast Cancer Really Not Justifiable?

      • Anthony B. Miller
      Pages 115-128

    3. How Reliable Is the Evidence for Screening Mammography?

      • Stephen A. Feig
      Pages 129-139

    4. Political Interpretation of Scientific Evidence — Case Study of Breast Cancer Screening Policies Around the World

      • Gad Rennert
      Pages 140-148

  7. Chemoprevention of Skin and Lung Cancer

    1. Front Matter

      Pages 149-149
      Download chapter PDF

    2. Skin Cancer Chemoprevention: Strategies to Save Our Skin

      • Janine G. Einspahr, G. Timothy Bowden, David S. Alberts
      Pages 151-164
Back to top

Keywords

About this book

Hans-Jorg Senn H.-J. Senn (~) Center for Tumor Detection and Prevention, Rorschacherstr. 150, CH-9006 St. Gallen, Switzerland Clinical oncology has centered mainly on developing new strategies and a multitude of new drugs for fighting relapsing and progressive cancer during the last two decades. Furthermore, it has done this with respectable success in quite a number of neoplastic diseases such as acute leukemias and sarcomas in pediatric patients and certain types of aggressive lymphomas, as well as se­ lected solid tumors such as testicular cancer and choriocarcinoma in adult age. Curatively intended adjuvant chemo-and endocrine-therapies of several "main killers" among prevalent cancer types, especially breast and colon can­ cer, have also become successful and health-politically meaningful therapeutic targets [1, 2]. However, the net gain in "cure" of these (mostly pharmacologic) therapeu­ tic approaches has to be realistically judged as having a moderate impact on the cancer problem as a whole, and the mortality rate of the most frequent tu­ mor types, which are prevalent in adult life, has with very few exceptions not been substantially decreased over the past two to three decades. Increasingly, health politicians, epidemiologists, and medical journal editors are asking for alternative strategies of lowering cancer incidence and increasing survival, ventilating new and hitherto mostly neglected areas of research such as pri­ mary and secondary cancer prevention.

Editors and Affiliations

  • Zentrum für Tumordiagnostik und Prävention, St. Gallen, Switzerland

    Hans-Jörg Senn, Rudolf Morant

Bibliographic Information

  • Book Title: Tumor Prevention and Genetics

  • Editors: Hans-Jörg Senn, Rudolf Morant

  • Series Title: Recent Results in Cancer Research

  • DOI: https://doi.org/10.1007/978-3-642-55647-0

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag Berlin Heidelberg 2003

  • Hardcover ISBN: 978-3-540-44062-8Due: 08 May 2003

  • Softcover ISBN: 978-3-642-62892-4Published: 08 October 2012

  • eBook ISBN: 978-3-642-55647-0Published: 06 December 2012

  • Series ISSN: 0080-0015

  • Series E-ISSN: 2197-6767

  • Edition Number: 1

  • Number of Pages: VII, 266

  • Topics: Cancer Research, Oncology, Human Genetics

Publish with us

Policies and ethics

Back to top

Search

Navigation